mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-07 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-07 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-07 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
5e-07 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.25 |
7e-07 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
9e-07 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
1e-06 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
1e-06 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-06 |